Geode Capital Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
1,510,749
-15,781
| -1% | -$39K | ﹤0.01% | 2880 |
|
|
2025
Q1 | $3.04M | Buy |
1,526,530
+58,924
| +4% | +$117K | ﹤0.01% | 2882 |
|
|
2024
Q4 | $4.29M | Buy |
1,467,606
+107,627
| +8% | +$314K | ﹤0.01% | 2813 |
|
|
2024
Q3 | $5.26M | Buy |
1,359,979
+63,456
| +5% | +$246K | ﹤0.01% | 2734 |
|
|
2024
Q2 | $6.67M | Buy |
1,296,523
+379,662
| +41% | +$1.95M | ﹤0.01% | 2573 |
|
|
2024
Q1 | $6.42M | Buy |
916,861
+29,358
| +3% | +$206K | ﹤0.01% | 2564 |
|
|
2023
Q4 | $7.86M | Buy |
887,503
+40,866
| +5% | +$362K | ﹤0.01% | 2466 |
|
|
2023
Q3 | $8.08M | Buy |
846,637
+306,329
| +57% | +$2.92M | ﹤0.01% | 2389 |
|
|
2023
Q2 | $7.92M | Buy |
540,308
+299,963
| +125% | +$4.39M | ﹤0.01% | 2432 |
|
|
2023
Q1 | $2.96M | Buy |
240,345
+6,050
| +3% | +$74.4K | ﹤0.01% | 2865 |
|
|
2022
Q4 | $4.35M | Buy |
+234,295
| New | +$4.35M | ﹤0.01% | 2739 |
|